论文部分内容阅读
虽然骶神经调节术(sacralneuromodulation,SNM)1997年才被美国FDA批准用于临床,但是骶神经调节治疗排尿功能障碍这一概念的形成最早可以追溯到50年前。20世纪60年代心脏起搏器取得成功后,人们试图通过电刺激驱动身体其他器官工作的热情开始高涨~([1])。20世纪70年代初,美国国立卫生研究院(NIH)开始了一系列研究,目标是通过电刺激获得协同排尿。虽然这一目标没有完全实现,但获得了间歇性排尿,也标志着骶神经调节的黎明已经到来~([1-2])。在美敦力公司的资助下,Schmidt等~([3])于1979年开始在
Although sacral neuromodulation (SNM) was only approved by the FDA in 1997 for clinical use, the concept of sacral neuromodulation in treating voiding dysfunction was first established 50 years ago. After the success of pacemakers in the 1960s, the enthusiasm of people trying to drive the work of other organs of the body through electrical stimulation began to rise ~ ([1]). In the early 1970s, the National Institutes of Health (NIH) began a series of studies with the goal of obtaining coordinated urination via electrical stimulation. Although this goal was not fully realized, intermittent urination was obtained, which also marked the dawn of sacral neuromodulation has arrived ~ ([1-2]). With support from Medtronic, Schmidt et al. ([3]) began in 1979